Skip to main content
. 2019 May 13;9:7260. doi: 10.1038/s41598-019-43677-7

Figure 2.

Figure 2

Novel DREAM ligands by structure-based chemical design. (a) Superposition of two different binding poses of IQM-PC205 with DREAM. Locations of the Tyr118 and Tyr130 residues are indicated (cyan). (b) Design approach and chemical structures. (c) Direct binding of selected compounds (16–18, IQM-PC332, 33–35, IQM-PC330) to immobilized DREAM in comparison with the hit IQM-PC205, CL-888 (positive control) and glibenclamide (Gb, negative control) determined by SPR spectroscopy. RU, resonance units. (d) SPR binding plot. IQM-PC330 KD = 3.9 ± 0.4 · 10−5 M; IQM-PC332 KD = 2.8 ± 0.3 · 10−5 M. (e) Calcium concentration dependency of the IQM-PC compounds to bind DREAM (f) Magnesium concentration dependency of the IQM-PC compounds to bind DREAM.